{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:17:22Z","timestamp":1792271842981,"version":"4.4.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Graves\u2019 orbitopathy (GO) is a complex and poorly understood disease in which extensive remodeling of orbital tissue is dominated by adipogenesis and hyaluronan production. The resulting proptosis is disfiguring and underpins the majority of GO signs and symptoms. While there is strong evidence for the thyrotropin receptor (TSHR) being a thyroid\/orbit shared autoantigen, the insulin-like growth factor 1 receptor (IGF1R) is also likely to play a key role in the disease. The pathogenesis of GO has been investigated extensively in the last decade with further understanding of some aspects of the disease. This is mainly derived by using <jats:italic>in vitro<\/jats:italic> and <jats:italic>ex vivo<\/jats:italic> analysis of the orbital tissues. Here, we have summarized the features of GO pathogenesis involving target autoantigens and their signaling pathways.<\/jats:p>","DOI":"10.3389\/fendo.2021.739994","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T05:31:25Z","timestamp":1636435885000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Orbital Signaling in Graves\u2019 Orbitopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Mohd Shazli","family":"Draman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Ludgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"B1","first-page":"99","article-title":"Prevalence of Graves' Ophthalmopathy in Patients With Graves' Disease Presenting to a Referral Centre in North India","volume":"139","author":"Reddy","year":"2014","journal-title":"Indian J Med Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01445.x","article-title":"Graves' Ophthalmopathy in Relation to Cigarette Smoking and Ethnic Origin","volume":"36","author":"Tellez","year":"1992","journal-title":"Clin Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and Prevention of Graves' Ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center","volume":"98","author":"Tanda","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","article-title":"Adipogenesis in Thyroid Eye Disease","volume":"41","author":"Crisp","year":"2000","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031427","article-title":"Evidence for Enhanced Adipogenesis in the Orbits of Patients With Graves' Ophthalmopathy","volume":"89","author":"Kumar","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1210\/jc.83.3.998","article-title":"Thyrotropin Receptor Expression in Graves' Orbital Adipose\/Connective Tissues: Potential Autoantigen in Graves' Ophthalmopathy","volume":"83","author":"Bahn","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/endo.130.4.1547715","article-title":"Thyrotropin Receptor Messenger Ribonucleic Acid Is Expressed in Most Brown and White Adipose Tissues in the Guinea Pig","volume":"130","author":"Roselli-Rehfuss","year":"1992","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.1175","article-title":"The Combination of Absent Thyroid Peroxidase Antibodies and High Thyroid-Stimulating Immunoglobulin Levels in Graves' Disease Identifies a Group at Markedly Increased Risk of Ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"B10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1055\/s-0035-1555956","article-title":"Modeling Graves' Orbitopathy in Experimental Graves' Disease","volume":"47","author":"Banga","year":"2015","journal-title":"Horm Metab Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.005","article-title":"Epidemiology of Graves' Orbitopathy (GO) and Relationship With Thyroid Disease","volume":"26","author":"Lazarus","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","article-title":"Graves' Orbitopathy as a Rare Disease in Europe: A European Group on Graves' Orbitopathy (EUGOGO) Position Statement","volume":"12","author":"Perros","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in Newly Diagnosed Graves' Disease Phenotype Between the Twentieth and the Twenty-First Centuries: Meta-Analysis and Meta-Regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.11.001","article-title":"Quality of Life in Graves' Ophthalmopathy","volume":"26","author":"Wiersinga","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0205","article-title":"Psychological Implications of Graves' Orbitopathy","volume":"157","author":"Coulter","year":"2007","journal-title":"Eur J Endocrinol  Eur Fed Endocrine Societies"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.16.1.145","article-title":"Molecular Regulation of Adipogenesis","volume":"16","author":"Rosen","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90006-x","article-title":"Stimulation of Adipogenesis in Fibroblasts by PPAR Gamma 2, a Lipid-Activated Transcription Factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402297200","article-title":"Protein Kinase B\/AKT 1 Plays a Pivotal Role in Insulin-Like Growth Factor-1 Receptor Signaling Induced 3T3-L1 Adipocyte Differentiation","volume":"279","author":"Xu","year":"2004","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011729200","article-title":"DNA Synthesis and Mitotic Clonal Expansion Is Not a Required Step for 3T3-L1 Preadipocyte Differentiation Into Adipocytes","volume":"276","author":"Qiu","year":"2001","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-09-0099","article-title":"Gsalpha Signalling Suppresses PPARgamma2 Generation and Inhibits 3T3L1 Adipogenesis","volume":"202","author":"Zhang","year":"2009","journal-title":"J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0300369","article-title":"Adipose Thyrotrophin Receptor Expression Is Elevated in Graves' and Thyroid Eye Diseases Ex Vivo and Indicates Adipogenesis in Progress In Vivo","volume":"30","author":"Starkey","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16610","article-title":"Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem\/Stromal Cells","volume":"56","author":"Brandau","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.9.8784110","article-title":"Evidence of Adipocyte Differentiation in Human Orbital Fibroblasts in Primary Culture","volume":"81","author":"Sorisky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16580","article-title":"Mesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy","volume":"56","author":"Kozdon","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4557","article-title":"Double Vision Is a Major Manifestation in Moderate to Severe Graves' Orbitopathy, But It Correlates Negatively With Inflammatory Signs and Proptosis","volume":"100","author":"Laurberg","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.003616","article-title":"Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts: Contributory Role in Hyaluronan Accumulation in Thyroid Dysfunction","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0596","article-title":"Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes","volume":"47","author":"Zhang","year":"2006","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8411","article-title":"Demonstration of Immunoglobulin G, A, and E Autoantibodies to the Human Thyrotropin Receptor Using Flow Cytometry","volume":"87","author":"Metcalfe","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2009.01.006","article-title":"The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling","volume":"38","author":"Latif","year":"2009","journal-title":"Endocrinol Metab Clinics North Am"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(98)00030-8","article-title":"Molecular Basis of Receptor\/G-Protein-Coupling Selectivity","volume":"80","author":"Wess","year":"1998","journal-title":"Pharmacol Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.9.8756566","article-title":"Multimeric Complex Formation by the Thyrotropin Receptor in Solubilized Thyroid Membranes","volume":"137","author":"Graves","year":"1996","journal-title":"Endocrinology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103727200","article-title":"Oligomerization of the Human Thyrotropin Receptor: Fluorescent Protein-Tagged hTSHR Reveals Post-Translational Complexes","volume":"276","author":"Latif","year":"2001","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206693200","article-title":"Ligand-Dependent Inhibition of Oligomerization at the Human Thyrotropin Receptor","volume":"277","author":"Latif","year":"2002","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.3.2191","article-title":"Lipid-Dependent Targeting of G Proteins Into Rafts","volume":"275","author":"Moffett","year":"2000","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)36705-4","article-title":"The Human Thyrotropin Receptor Activates G-Proteins Gs and Gq\/11","volume":"269","author":"Allgeier","year":"1994","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.1.116","article-title":"The Human Thyrotropin Receptor: A Heptahelical Receptor Capable of Stimulating Members of All Four G Protein Families","volume":"93","author":"Laugwitz","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-251124","article-title":"Beta-Arrestin-1 Mediates Thyrotropin-Enhanced Osteoblast Differentiation","volume":"28","author":"Boutin","year":"2014","journal-title":"FASEB J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M800211200","article-title":"G13-Dependent Activation of MAPK by Thyrotropin","volume":"283","author":"B\u00fcch","year":"2008","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(87)90055-4","article-title":"Dual Activation by Thyrotropin of the Phospholipase C and Cyclic AMP Cascades in Human Thyroid","volume":"52","author":"Laurent","year":"1987","journal-title":"Mol Cell Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0079-6336(11)80074-4","article-title":"Robert Feulgen Lecture 1991. Control and Role of Major Signalling Cascades of the Thyrocyte","volume":"26","author":"Raspe","year":"1992","journal-title":"Prog Histochem Cytochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242328999","article-title":"Role of the Thyroid-Stimulating Hormone Receptor Signaling in Development and Differentiation of the Thyroid Gland","volume":"99","author":"Postiglione","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1210\/edrv-13-3-596","article-title":"The Thyrotropin Receptor and the Regulation of Thyrocyte Function and Growth","volume":"13","author":"Vassart","year":"1992","journal-title":"Endocrine Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20405","article-title":"TGF-Beta Induced Hyaluronan Synthesis in Orbital Fibroblasts Involves Protein Kinase C betaII Activation In Vitro","volume":"95","author":"Wang","year":"2005","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.4.7714082","article-title":"Physiological Concentrations of Thyrotropin Increase Cytosolic Calcium Levels in Primary Cultures of Human Thyroid Cells","volume":"80","author":"D'Arcangelo","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)53300-7","article-title":"Cloning, Sequencing, Purification, and Gq-Dependent Activation of Phospholipase C-Beta 3","volume":"268","author":"Jhon","year":"1993","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nri1632","article-title":"NFAT Proteins: Key Regulators of T-Cell Development and Function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.8907","article-title":"Interaction of Calcineurin With a Domain of the Transcription Factor NFAT1 That Controls Nuclear Import","volume":"93","author":"Luo","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.36.040196.002333","article-title":"Complexity and Diversity of Mammalian Adenylyl Cyclases","volume":"36","author":"Sunahara","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(97)01061-X","article-title":"Phosphoinositide 3-Kinases: A Conserved Family of Signal Transducers","volume":"22","author":"Vanhaesebroeck","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.24.15045","article-title":"Regulation of Phosphoinositide-Specific Phospholipase C Isozymes","volume":"272","author":"Rhee","year":"1997","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.279.2.C335","article-title":"Functional TSH Receptor in Human Abdominal Preadipocytes and Orbital Fibroblasts","volume":"279","author":"Bell","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0123","article-title":"Thyrotropin Receptor-Stimulating Graves' Disease Immunoglobulins Induce Hyaluronan Synthesis by Differentiated Orbital Fibroblasts From Patients With Graves' Ophthalmopathy Not Only via Cyclic Adenosine Monophosphate Signaling Pathways","volume":"21","author":"van Zeijl","year":"2011","journal-title":"Thyroid"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0520","article-title":"A Drug-Like Antagonist Inhibits Thyrotropin Receptor\u2013Mediated Stimulation of cAMP Production in Graves' Orbital Fibroblasts","volume":"22","author":"Neumann","year":"2012","journal-title":"Thyroid"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1299","article-title":"Adipose Tissue Depot-Specific Differences in the Regulation of Hyaluronan Production of Relevance to Graves' Orbitopathy","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239145","article-title":"Distinctive Features of Orbital Adipose Tissue (OAT) in Graves' Orbitopathy","volume":"21","author":"Zhang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"bqab188","DOI":"10.1210\/endocr\/bqab188","article-title":"The Role of Mitochondria Linked Fatty-Acid Uptake-Driven Adipogenesis in Graves' Orbitopathy","volume":"162","author":"Zhang","year":"2021","journal-title":"Endocrinology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 Binding Sites in Thyroid Associated Ophthalmopathy","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an Association Between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00167","article-title":"Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy","volume":"7","author":"Smith","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00066","article-title":"Insulin-Like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy","volume":"40","author":"Smith","year":"2019","journal-title":"Endocrine Rev"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4182","article-title":"Possible Targets for Nonimmunosuppressive Therapy of Graves' Orbitopathy","volume":"99","author":"Zhang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 Receptor Cross Talk Mediates Stimulation of Hyaluronan Secretion by Graves' Disease Immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2932","article-title":"Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs","volume":"101","author":"Zhang","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for Patients With Active Thyroid Eye Disease: A Pooled Data Analysis, Subgroup Analyses, and Off-Treatment Follow-Up Results From Two Randomised, Double-Masked, Placebo-Controlled, Multicentre Trials","volume":"9","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for Thyroid-Associated Ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0717-8","article-title":"Teprotumumab: A New Avenue for the Management of Moderate-to-Severe and Active Graves' Orbitopathy","volume":"40","author":"Piantanida","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature06027","article-title":"IGF and FGF Cooperatively Establish the Regulatory Stem Cell Niche of Pluripotent Human Cells","volume":"448","author":"Bendall","year":"2007","journal-title":"Vitro Nat"},{"key":"B69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/thy.2018.0544","article-title":"Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy","volume":"29","author":"Schrijver","year":"2019","journal-title":"Thyroid"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(92)91315-h","article-title":"Cloning and Sequencing of a 1.3 KB Variant of Human Thyrotropin Receptor mRNA Lacking the Transmembrane Domain","volume":"187","author":"Graves","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.5.7962314","article-title":"Presence of Nonfunctional Thyrotropin Receptor Variant Transcripts in Retroocular and Other Tissues","volume":"79","author":"Paschke","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2003.03718.x","article-title":"Role of Cleavage and Shedding in Human Thyrotropin Receptor Function and Trafficking","volume":"270","author":"Quellari","year":"2003","journal-title":"Eur J Biochem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0170","article-title":"The Thyrotropin Receptor in Graves' Disease","volume":"17","author":"Rapoport","year":"2007","journal-title":"Thyroid"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1530\/joe-11-0162","article-title":"Orbital Fibrosis in a Mouse Model of Graves' Disease Induced by Genetic Immunization of Thyrotropin Receptor cDNA","volume":"210","author":"Zhao","year":"2011","journal-title":"J Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1576","article-title":"Cutting Edge: Retrobulbar Inflammation, Adipogenesis, and Acute Orbital Congestion in a Preclinical Female Mouse Model of Graves' Orbitopathy Induced by Thyrotropin Receptor Plasmid-In Vivo Electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/cimb43030126","article-title":"Expression of Endogenous Putative TSH Binding Protein in Orbit","volume":"43","author":"Draman","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1530\/JME-18-0213","article-title":"Crystal Structure of a Ligand-Free Stable TSH Receptor Leucine-Rich Repeat Domain","volume":"62","author":"Miller-Gallacher","year":"2019","journal-title":"J Mol Endocrinol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000511538","article-title":"Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease","volume":"9","author":"Neumann","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1597\u2013602","DOI":"10.1089\/thy.2021.0053","article-title":"Blocking the TSH Receptor With K1-70\u2122 in a Patient With Follicular Thyroid Cancer, Graves' Disease and Graves' Ophthalmopathy","volume":"31","author":"Ryder","year":"2021","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.739994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T05:31:30Z","timestamp":1636435890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.739994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":79,"alternative-id":["10.3389\/fendo.2021.739994"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.739994","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"article-number":"739994"}}